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Impairments in memory and cognitive function are characteristic symptoms of stress-related disorders, but the relationship between stress and memory is complex. Recent findings suggest that hippocampal inflammatory processes contribute to spatial memory deficits in the rodent social defeat model that can be reversed by anti-inflammatory treatment with minocycline.
At least 20% of patients with stress-related disorders meet criteria for cognitive impairment [1] . Cognitive symptoms include diminished concentration, impaired working memory, and an enhanced negative bias in thinking [2] . These impairments are often maintained in remission, indicating that current antidepressant treatments insufficiently address cognitive symptoms. Reduced hippocampal activation and neurogenesis along with hormonal and inflammatory processes have been implicated in stress-related cognitive impairments; however, the precise mechanisms remain incompletely defined. A recent paper by McKim and colleagues [3] provides important new insight, demonstrating a prominent role for neuroinflammation, but not hippocampal neurogenesis, in memory impairments induced by social defeat stress. Social defeat stress, which involves the repeated social subordination of an experimental mouse by a larger, physically aggressive mouse, recapitulates many of the symptoms of depression, including anhedonia, social avoidance, weight change, and circadian disruption [4, 5] . Importantly, social defeat also activates the immune system, producing lasting changes in peripheral and central cytokine levels, microglial activation, number and sensitivity of circulating leukocytes, and monocyte recruitment to the brain [6-9].
McKim et al. assessed the effects of social defeat-induced neuroinflammatory processes on learning and memory, hippocampal neurogenesis, and social avoidance behavior. Mice were exposed to Repeated Social Defeat (RSD), a version of social defeat stress in which a novel, aggressive CD-1 intruder mouse is placed in the home cage of three C57BL/6 mice for a two hour period over six consecutive nights. The intruder mouse disrupts the established social hierarchy of the trio and elicits submissive behaviors. The authors found that RSD induced a pro-inflammatory profile along with neurogenesis deficits in the hippocampus of mice exposed to RSD compared to unstressed controls. They observed increased hippocampal cytokine and growth factor gene expression (IL-1b, TNF-/, IL-6, VEGF), enhanced microglial Iba-1 immunoreactivity in the dentate gyrus (DG), and an increase in DG CD45-positive cells in RSD mice, suggesting recruitment of peripheral monocytes to the brain ( Figure 1B,C) . While the authors found no differences between RSD and control mice in cell proliferation in the DG, they reported reduced colocalization of BrdU (5 0 bromodeoxyuridine) with DCX (doublecortin, an immature neuronal marker) and NeuN (a mature neuronal marker) at 10 and 28 days post-stress, respectively, in RSD mice, indicating impaired differentiation of neural progenitor cells (NPCs) into mature neurons ( Figure 1A ). These cellular changes were most pronounced in the caudal hippocampus and accompanied behavioral changes in memory and mood. RSD mice showed a mild, short-lived impairment in Morris water maze working memory stemming from an anxiety-related thigmotactic search strategy. However, unrelated to anxiety, as validated in the Barnes maze, RSD mice also demonstrated impaired short-term spatial memory recall, but not acquisition or long-term recall, 28 days after stress. RSD mice also displayed increased social avoidance in a social interaction test. To determine the necessity of neuroinflammation for RSDinduced behavioral changes, the authors treated mice with minocycline, an antibiotic with anti-inflammatory properties, prior to RSD exposure. Minocycline abrogated the RSD-induced increase in Iba-1 immunoreactivity and monocyte recruitment, and prevented spatial memory recall deficits in the Barnes maze. However, minocycline did not rescue social avoidance or NPC differentiation into mature neurons in RSD mice, leading the authors to conclude that neuroinflammation mediates the cognitive, but not long-term emotional, impairments produced by RSD.
The rescue of the central inflammatory and cognitive effects of RSD by minocycline highlights the role of inflammation in stress-induced behavioral changes and identifies a potential therapy for patients experiencing stress-related cognitive impairment. As such, this work has interesting implications for post-traumatic stress disorder as well as depression. Minocycline is a broad spectrum antibiotic that easily crosses the blood-brain barrier into the CNS, where it is has been shown to inhibit microglial activation, cytokine signaling, and immune cell infiltration [10] . Interestingly, minocycline has shown efficacy as an adjunct to traditional antidepressants in an open label trial for psychotic depression, with patients demonstrating significant improvement in depressive and psychotic symptoms [11] . However, the effect of minocycline on cognitive symptoms has not been assessed clinically in patients with stress-related disorders. It is surprising that an anti-inflammatory compound did not alleviate social avoidance as previous work shows that manipulating the 
